DR info

Clinical trials : 18 / Drugs : 26 - (DrugBank : 14) / Drug target genes : 13 - Drug target pathways : 45

Tetralogy of Fallot and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
215	Tetralogy of Fallot
6	Parkinson disease
5	Progressive supranuclear palsy
46	Malignant rheumatoid arthritis
13	Multiple sclerosis/Neuromyelitis optica
17	Multiple system atrophy
70	Spinal stenosis
96	Crohn disease
113	Muscular dystrophy
85	Idiopathic interstitial pneumonia
2	Amyotrophic lateral sclerosis
127	Frontotemporal lobar degeneration
4	Primary lateral sclerosis
78	Hypopituitarism
3	Spinal muscular atrophy
169	Menkes disease
170	Occipital horn syndrome
21	Mitochondrial disease
206	Fragile X syndrome
8	Huntington disease
86	Pulmonary arterial hypertension
323	Aromatic L-amino acid decarboxylase deficiency
97	Ulcerative colitis
22	Moyamoya disease
203	22q11.2 deletion syndrome
11	Myasthenia gravis
58	Hypertrophic cardiomyopathy
90	Retinitis pigmentosa
118	Myelomeningocele
226	Interstitial cystitis with Hunners ulcer
34	Neurofibromatosis
65	Primary immunodeficiency
49	Systemic lupus erythematosus
167	Marfan syndrome
205	Fragile X syndrome related disease
278	Huge lymphatic malformation with cervicofacial lesion
18	Spinocerebellar degeneration
280	Huge arteriovenous malformation with cervicofacial or limb lesion
222	Primary nephrotic syndrome
156	Rett syndrome
288	Autoimmune acquired coagulation factor deficiency
102	Rubinstein-Taybi syndrome
212	Tricuspid atresia
227	Osler disease
89	Lymphangioleiomyomatosis
57	Idiopathic dilated cardiomyopathy
256	Muscle glycogenosis
233	Wolfram syndrome
111	Congenital myopathy